Top Legislation - View All
Also tagged in: Administrative procedure, Administrative remedies, Business, Department of Health and Human Services, Drug approvals, Drug industry, Executive departments, Fines (Penalties), Governmental investigations, Law, Legal fees, Marketing, Medical care, Medicine
Latest Action: 01/04/2007 - Sponsor introductory remarks on measure. (CR S64-65) Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act to establish requirements for certain petitions submitted to the Food and Drug Administration, and for other purposes. 1/4/2007--Introduced. Citizen Petition Fairness and Accuracy Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require that any citizen petition or request for stay of action related to an abbreviated new drug application include a statement that to the petitioner's best knowledge and belief, the petition: (1) includes all information and views on which the petitioner relies; (2) is well grounded in fact and is warranted by law; (3) is not submitted for an improper purpose; and (4) does not contain a materially false, misleading, or fraudulent statement. Requires the Secretary of Health and Human Services to investigate any petition that does not comply with such requirements. Allows the Secretary to impose penalties for knowingly and willfully submitting a petition for an improper [...] show full description
Also tagged in: Abortion, Administrative procedure, Congress, Congressional investigations, Congressional reporting requirements, Congressional veto, Consumers, Department of Health and Human Services, Drug approvals, Drugs, Executive departments, Government information, Government publicity, Labeling, Law, Medical care, Medicine
Latest Action: 02/02/2007 - Referred to the Subcommittee on Health. Bill TextTo provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug commonly known as RU-486 is deemed to have been withdrawn, to provide for the review by the Comptroller General of the United States of the process by which the Food and Drug Administration approved such drug, and for other purposes. 1/4/2007--Introduced. RU-486 Suspension and Review Act of 2007 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been withdrawn. Deems the drug misoprostol to be misbranded under the Federal Food, Drug, and Cosmetic Act (FFDCA) if it bears labeling providing that the drug may be used for the medical termination of intrauterine pregnancy. Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the [...] show full description
Also tagged in: Affordable housing, Afghanistan, Aged, Agricultural subsidies, Agriculture, Alcohol as fuel, Alien labor, Alternative energy sources, Appropriations, Armed forces, Armed forces abroad, Authorization, Border patrols, Budget deficits, Budget reconciliation, Budget resolutions, Budget surpluses, Budgets, Business, Children, College costs, Congress, Congressional agencies, Congressional Budget Office, Congressional committees (Senate), Congressional conference committees, Congressional voting, Counterterrorism, Criminal justice, Day care, Debt limit, Defense budgets, Defense economics, Defense policy, Department of Health and Human Services, Disability evaluation, Disabled, District of Columbia, Drug utilization, Economic policy, Electric power transmission, Electric vehicles, Electronic data interchange, Emergency management, Employee health benefits, Energy, Energy conservation, Energy crops, Energy efficiency, Energy security, Executive departments, Federal aid to child health services, Federal aid to housing, Federal budget process, Finance, Fire prevention, Food, Foreign policy, Forest fires, Government securities, Government spending reductions, Government trust funds, Governmental investigations, Health care fraud, Health information systems, Health insurance, Health policy, Higher education, Housing, Illegal aliens, Immigration, Imports, Income tax, Indian claims, Information technology, International affairs, Iraq, Iraq compilation, Labor, Legislation, Legislative amendments, Legislative resolutions, Liability insurance, Logistics, Long-term care, Medical care, Medical fees, Medical records, Medically uninsured, Medicare, Medicine, Mental health services, Middle East and North Africa, Military and naval supplies, Military hospitals, Military medicine, Military occupation, Military operations, Military training, Minorities, Motor vehicles, National forests, Natural gas, Natural gas vehicles, Natural resources, Nutrition, Oil and gas royalties, Petroleum, Pharmaceutical research, Physicians, Poor children, Power marketing administrations, Prescription pricing, Prospecting, Public lands, Public-private partnerships, Quality of care, Revenue sharing, Right of privacy, Rural affairs, Rural economic development, Science policy, Senate Budget, Senate rules and procedure, Small business, Social security, Social security finance, South Asia, State and local government, Supplemental security income program, Tax administration, Tax refunds, Taxation, Technology, Telecommunication, Terrorism, Tobacco, Tobacco industry, Trade, Transportation, Unemployment insurance, User charges, Veterans, Veterans' benefits, Veterans' medical care, War casualties, War risk insurance, Welfare
Latest Action: 05/17/2007 - Conference papers: Senate report and manager's statement and message on House action held at the desk in Senate. Bill TextAn original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2008 and including the appropriate budgetary levels for fiscal years 2007 and 2009 through 2012. 5/16/2007--Conference report filed in House. (There are 4 other summaries) Sets forth the congressional budget for the federal government for FY2008, including the appropriate budgetary levels for FY2007 and FY2009-FY2012. Title I: Recommended Levels and Amounts - (Sec. 101) Lists recommended budgetary levels and amounts, for FY2007-FY2012, with respect to: (1) federal revenues; (2) new budget authority; (3) budget outlays; (4) deficits; (5) debt subject to limit; and (6) debt held by the public. (Sec. 102) Lists the appropriate levels of new budget authority, outlays, and administrative expenses for Social Security and specified major functional categories for FY2007-FY2012. Title II: Budget Process [...] show full description
Also tagged in: Accreditation (Medical care), Actions and defenses, Administrative fees, Administrative procedure, Administrative remedies, Australia, Budgets, Business, Business records, Canada, Checks, Civil liberties, Congress, Congressional reporting requirements, Consumer education, Consumers, Contracts, Credit cards, Criminal justice, Customs administration, Damages, Defective products, Department of Health and Human Services, Directories, Drug advertising, Drug approvals, Drug industry, Drugs, East Asia, Education, Electronic commerce, Electronic data interchange, Electronic funds transfers, Electronic government information, Europe, European Union, Evidence (Law), Executive departments, Export controls, Exports, Federal preemption, Federal Trade Commission, Federal-state relations, Finance, Fines (Penalties), Forfeiture, Fraud, Government information, Government paperwork, Government publicity, Governmental investigations, Higher education, Identification devices, Import restrictions, Imports, Independent regulatory commissions, Injunctions, Intellectual property, Interactive media, Internet, Japan, Labeling, Law, Liability (Law), Licenses, Medical associations, Medical care, Medical education, Medical records, Medical tests, Medicine, New Zealand, Oceania, Packaging, Parties to actions, Patent infringement, Patents, Pharmaceutical research, Pharmacies, Pharmacists, Physical examinations, Prescription pricing, Price discrimination, Product counterfeiting, Restrictive trade practices, Right of privacy, Science policy, State and local government, State laws, Surety and fidelity, Switzerland, Technology, Telecommunication, Telephone, Trade, User charges, Web sites, Wholesale trade
Latest Action: 02/02/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes. 1/10/2007--Introduced. Pharmaceutical Market Access and Drug Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.[...] show full description
Also tagged in: Administrative remedies, Advertising, Biomedical engineering, Business, Clinical trials, Congress, Congressional reporting requirements, Consumer education, Consumers, Cost effectiveness, Data banks, Department of Health and Human Services, Drug adulteration, Drug approvals, Drug industry, Epidemiology, Executive departments, Executive reorganization, Federal advisory bodies, Finance, Fines (Penalties), Government information, Government paperwork, Government publicity, Health information systems, Law, Licenses, Medical care, Medical instruments and apparatus, Medical supplies, Medicine, Pharmaceutical research, Product safety, Risk, Sales promotion, Science policy, Technology
Latest Action: 01/31/2007 - Sponsor introductory remarks on measure. (CR S1454-1455) Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act with respect to drug safety, and for other purposes. 1/31/2007--Introduced. Food and Drug Administration Safety Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to establish the Center for Postmarket Evaluation and Research for Drugs and Biologics within the Food and Drug Administration (FDA). Requires the Director of the Center to conduct activities to ensure the safety and effectiveness of FDA-approved drugs and licensed biological products, including by: (1) conducting postmarket risk assessment and surveillance of such drugs and products; (2) determining whether a postmarket study is required; (3) contracting, or requiring the sponsor of such a drug or product to contract, with the holders of domestic and international patient databases to conduct epidemiologic and other observational studies; (4) determining whether a drug or product may present an unreasonable risk to the health of patients [...] show full description
Also tagged in: Biomedical engineering, Business, Clinical trials, Conflict of interests, Congress, Congressional reporting requirements, Consumers, Corporations, Data banks, Department of Health and Human Services, Drug approvals, Drug industry, Drug interactions, Drug utilization, Drugs, Executive departments, Executive reorganization, Federal advisory bodies, Finance, Financial disclosure, Generic drugs, Government information, Government paperwork, Government publicity, Health information systems, Labeling, Medical care, Medical instruments and apparatus, Medical supplies, Medical technology, Medicine, Nonprofit organizations, Pharmaceutical research, Politics and government, Product development, Product safety, Research centers, Risk, Science policy, Social services, Technological innovations, Technology
Latest Action: 03/14/2007 - Committee on Health, Education, Labor, and Pensions. Hearings held. Bill TextA bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes. 2/1/2007--Introduced. Enhancing Drug Safety and Innovation Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require an application for approval for a new drug or biological product to include a proposed risk evaluation and mitigation strategy, which must include: (1) labeling for the drug for use by health care providers; (2) submission of reports for the drug; and (3) a statement as to whether the analysis and surveillance are sufficient to assess the serious risks of the drug. Establishes a Drug Safety Oversight Board. Requires the Secretary of Health and Human Services to establish the Reagan-Udall Institute for Applied Biomedical Research as a nonprofit corporation to advance the Critical Path Initiative to modernize medical product development, accelerate innovation, and enhance product [...] show full description
Also tagged in: Administrative procedure, Agriculture, Business, Consumers, Dairy industry, Dairy products, Department of Health and Human Services, Executive departments, Farmers, Food, Food labeling, Labeling, Law, Milk, Proteins
Latest Action: 02/08/2007 - Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry. (text of measure as introduced: CR S1786) Bill TextA bill to prohibit products that contain dry ultra-filtered milk products, milk protein concentrate, or casein from being labeled as domestic natural cheese, and for other purposes. 2/8/2007--Introduced. Quality Cheese Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the Commissioner of the Food and Drug Administration from using federal funds to amend specified regulations to include dry ultra-filtered milk, milk protein concentrate, or casein in the definition of "milk" or "nonfat milk" as specified in the domestic natural standards for cheese and cheese products.
Also tagged in: Administrative remedies, Animal diseases, Animals, Consumer education, Consumers, Department of Health and Human Services, Executive departments, Government information, Government paperwork, Law, Medical care, Medicine, Pets, Preventive medicine, Retail trade, Salmonella, Turtles, Veterinary medicine
Latest Action: 02/08/2007 - Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry. Bill TextA bill to require the Food and Drug Administration to permit the sale of baby turtles as pets so long as the seller uses proven methods to effectively treat salmonella. 2/8/2007--Introduced. Domestic Pet Turtle Market Access Act of 2007 - Prohibits the Food and Drug Administration (FDA) from restricting the sale by a turtle farmer or other commercial retail seller of a turtle that is less than 10.2 centimeters in diameter as a pet if: (1) the turtle is raised, shipped, and sold using methods proven to keep the turtle free of salmonella, using salmonella safety standards comparable to standards for other animals allowed for sale as pets or animal products allowed for sale as food products; (2) the FDA has approved a plan submitted by the turtle farmer or seller relating to compliance with this Act; and (3) the farmer or seller makes certain disclosures to the buyer. Sets forth required disclosures, which include: (1) information regarding the dangers that could result if the [...] show full description
Also tagged in: Accreditation (Medical care), Actions and defenses, Administrative fees, Administrative procedure, Administrative remedies, Aged, Appropriations, Armed forces, Auditing, Australia, Budgets, Business, Business records, Canada, Capital gains tax, Caribbean area, Checks, Citizenship, Civil liberties, Claims, Competitive bidding, Conflict of interests, Congress, Congressional reporting requirements, Consumer education, Consumers, Continental shelf, Contracts, Corporation taxes, Cost of living adjustments, Courts of special jurisdiction, Credit cards, Criminal justice, Cuba, Customs administration, Damages, Data banks, Defective products, Defense contracts, Defense economics, Department of Defense, Department of Health and Human Services, Department of Homeland Security, Department of the Interior, Department of the Treasury, Directories, Disciplining of employees, Dividends, Drug advertising, Drug approvals, Drug industry, Drugs, Due process of law, East Asia, Education, Electronic commerce, Electronic data interchange, Electronic funds transfers, Electronic government information, Employee rights, Energy, Environmental Protection Agency, Europe, European Union, Evidence (Law), Executive departments, Expatriation, Export controls, Exports, Federal Emergency Management Agency, Federal employees, Federal officials, Federal preemption, Federal Trade Commission, Federal-state relations, Fees, Finance, Fines (Penalties), Foreign corporations, Foreign policy, Foreign tax credit, Forfeiture, Fraud, Gas in submerged lands, General Services Administration, Gifts, Government contractors, Government employees, Government information, Government paperwork, Government procurement, Government publicity, Government spending reductions, Governmental investigations, Gulf of Mexico, Health policy, Higher education, Identification devices, Immigration, Import restrictions, Imports, Income tax, Independent regulatory commissions, Indexing (Economic policy), Infrastructure, Infrastructure (Economics), Injunctions, Intellectual property, Intelligence activities, Interactive media, International broadcasting, Internet, Japan, Judicial review, Jurisdiction, Labeling, Latin America, Law, Legal fees, Liability (Law), Licenses, Lobbying, Medical associations, Medical care, Medical education, Medical records, Medical tests, Medicare, Medicine, Minimum tax, New Zealand, Oceania, Office of Government Ethics, Office of Management and Budget, Office of Special Counsel, Oil and gas leases, Oil and gas royalties, Oil well drilling, Overhead costs, Packaging, Parties to actions, Patent infringement, Patents, Petroleum in submerged lands, Pharmaceutical research, Pharmacies, Pharmacists, Physical examinations, Politics and government, Prescription pricing, Presidential appointments, Presidents, Price discrimination, Product counterfeiting, Profit, Public contracts, Restrictive trade practices, Right of privacy, Science policy, Security clearances, State and local government, State laws, Sunset legislation, Surety and fidelity, Switzerland, Tax deductions, Tax deferral, Tax exclusion, Tax exemption, Tax liens, Tax rates, Tax shelters, Taxation of foreign income, Technology, Telecommunication, Telephone, Television broadcasting, Trade, User charges, Web sites, Whistle blowing, Wholesale trade
Latest Action: 02/12/2007 - Sponsor introductory remarks on measure. (CR S1855-1857) Bill TextA bill to reduce the Federal budget deficit, and for other purposes. 2/12/2007--Introduced. Act for Our Kids - Repeals the Television Broadcasting to Cuba Act. Amends the Cuban Liberty and Democratic Solidarity (LIBERTAD) Act of 1996 to prohibit federal funding of television broadcasting to Cuba. Terminates the U.S. Court of Federal Claims. Requires federal agencies to reduce administrative expenses. Eliminates the Medicare Advantage Regional Plan Stabilization (SLUSH) Fund. Amends the federal criminal code to prohibit profiteering and fraud involving a contract or the provision of goods or services in connection with a war or military action. Requires: (1) suspension and debarment of unethical contractors; (2) disclosure by federal agencies, upon request, to the appropriate committee chairman or ranking member of audit reports regarding federal contractors; and (3) public access to information on federal contractor penalties and [...] show full description
Also tagged in: Access to health care, Administrative procedure, Aged, Business, Cardiovascular diseases, Clinical trials, Communication in medicine, Communication in science, Congress, Congressional investigations, Congressional reporting requirements, Data banks, Department of Health and Human Services, Drug approvals, Drug industry, Drugs, Education, Executive departments, Government information, Government paperwork, Government publicity, Governmental investigations, Health education, Health information systems, Health policy, Health surveys, Higher education, Hospital care, Indian medical care, Indian women, Indians, Law, Licenses, Medical care, Medical education, Medical instruments and apparatus, Medical malpractice, Medical records, Medical screening, Medical statistics, Medical supplies, Medical tests, Medically uninsured, Medicare, Medicine, Minorities, Minority health, Peer review organizations (Medicine), Pharmaceutical research, Physicians, Poverty, Preventive medicine, Quality of care, Science policy, Standards, Stroke, Technology, Welfare, Women, Women's health, Women's health services
Latest Action: 02/13/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. 2/13/2007--Introduced. Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - Amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to require an application for approval or for investigation of a drug, device, or biological product to include information stratified by sex, race, and ethnicity, including any differences in safety and effectiveness. Requires the Secretary of Health and Human Services to: (1) withhold approval of such an application or place a clinical hold on an investigation if such information is not included; and (2) report to the scientific community and make information available to the public on such stratified data upon approval of an application.Requires the Comptroller [...] show full description
|
Latest Legislation - View All
Also tagged in: Administrative fees, Administrative procedure, Animals, Appropriations, Authorization, Budgets, Business, Congress, Congressional reporting requirements, Department of Health and Human Services, Drug approvals, Drug industry, Electronic government information, Executive departments, Generic drugs, Government information, Government publicity, Health policy, Law, Medical care, Medicine, Pharmaceutical research, Science policy, Sunset legislation, Technology, Telecommunication, Veterinary medicine
Latest Action: 07/30/2008 - Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-805. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to establish a program of fees relating to generic new animal drugs. 7/30/2008--Reported to House amended. (There is 1 other summary) Animal Generic Drug User Fee Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.Authorizes appropriations for FY2009-FY2013.Requires the Secretary to report to Congress and make publicly available information [...] show full description
Also tagged in: Actions and defenses, Administrative fees, Administrative procedure, Administrative remedies, Budgets, Child health, Children, Clinical trials, Confidential communications, Department of Health and Human Services, Drug approvals, Drugs, Executive departments, Government information, Government publicity, Hazardous substances, Health policy, Intellectual property, Law, Licenses, Medical care, Medical supplies, Medicine, Patent infringement, Patents, Pharmaceutical research, Poisons, Science policy
Latest Action: 04/14/2008 - Referred to the Subcommittee on Courts, the Internet, and Intellectual Property. Bill TextTo amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. 3/13/2008--Introduced. Pathway for Biosimilars Act - Amends the Public Health Service Act to allow a person to submit an application for licensure of a biological product based on its similarity to a licensed biological product (the reference product).Requires the Secretary of Health and Human Services to approve the application if: (1) the biological product is biosimilar to the reference product with respect to each condition of use for which the reference product is approved; and (2) the applicant consents to the inspection of the facility that is the subject of the application. Sets forth requirements for a determination by the Secretary that a biological product is interchangeable with a reference product.Prohibits a biological product from being evaluated against more than one reference product.Prohibits [...] show full description
Also tagged in: Access to health care, Administrative procedure, Affordable housing, Afghanistan, Aged, Agricultural subsidies, Agriculture, Aid to dependent children, AIDS (Disease), Alternative energy sources, Animals, Appropriations, Armed forces, Armed forces abroad, Armed forces reserves, Auditing, Automobile industry, Balanced budgets, Bonds, Border patrols, Brain, Budget deficits, Budget resolutions, Budget surpluses, Budgets, Business, Cash welfare block grants, Child health, Child support, Children, Climate change, Coastal zone, Communications, Community health services, Congress, Congressional budget, Congressional conference committees, Congressional investigations, Congressional voting, Constitution, Constitutional amendments, Consumers, Criminal aliens, Criminal justice, Customs administration, Debt limit, Defense budgets, Defense contracts, Defense economics, Defense policy, Defense procurement, Dental care, Department of Commerce, Department of Health and Human Services, Deportation, Diabetes, Disability evaluation, Disabled, Disaster insurance, Drug approvals, Drugs, East Asia, Economic growth, Economic policy, Education, Emergency management, Employee health benefits, Energy, Energy efficiency, Energy security, Environmental protection, Executive departments, Families, Federal aid to child health services, Federal aid to education, Federal aid to housing, Federal aid to research, Federal aid to transportation, Federal aid to water resources development, Federal budget process, Finance, Financial statements, Floods, Food safety, Foreign policy, Government information, Government publicity, Government trust funds, Greenhouse gases, Head injuries, Health care fraud, Health information systems, Health insurance, Health policy, Higher education, Highway finance, History, Housing, Housing authorities, Housing subsidies, Human immunodeficiency viruses, Identification of criminals, Illegal aliens, Immigration, Import restrictions, Imports, Income tax, Indian claims, Indian medical care, Indian water rights, Infrastructure, Infrastructure (Economics), International affairs, Internet, Iraq, Iraq compilation, Job training, Judges, Judicial compensation, Labor, Law, Legislation, Legislative amendments, Legislative resolutions, Long-term care, Manufacturing industries, Marine resources, Marine resources conservation, Marketing, Mass rapid transit, Medicaid, Medical care, Medical education, Medical fees, Medical research, Medical residents, Medically uninsured, Medicare, Medicine, Mental health services, Middle East and North Africa, Military dependents, Military medicine, Military occupation, Military operations, Military pensions, Minimum tax, Mining royalties, Minorities, National Guard, National parks, Natural resources, Naturalization, New Mexico, Ocean, Old age, survivors and disability insurance, Pediatrics, Pennsylvania, Pensions, Performance measurement, Personnel records, Philippines, Physicians, Poor children, Postal service, Prescription pricing, Public broadcasting, Public debt, Public housing, Public lands, Quality of care, Research and development, Right of privacy, Sanctions (International law), Scholarships, School buildings, Science policy, Senate rules and procedure, September 11, 2001, Small business, Social security, Social security beneficiaries, Social security finance, South Asia, State and local government, Supplemental appropriations, Supplemental security income program, Tax administration, Tax credits, Tax deductions, Tax rates, Tax refunds, Taxation, Teachers, Teaching materials, Technological innovations, Technology, Telecommunication, Trade, Trade adjustment assistance, Trade agreements, Transportation, Trauma care, Unemployment insurance, United States Postal Service, User charges, Veterans, Veterans' benefits, Veterans' disability compensation, Veterans' education, Veterans' medical care, Veterinary medicine, War casualties, Waste in government spending, Water resources, Water supply, Web sites, Welfare, Welfare work participation, World War II
Latest Action: 06/05/2008 - Mr. Spratt brought up conference report H. Rept. 110-659 for consideration under the provisions of H. Res. 1214. Bill TextAn original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2009 and including the appropriate budgetary levels for fiscal years 2008 and 2010 through 2013. 5/20/2008--Conference report filed in House. (There are 4 other summaries) Sets forth the congressional budget for the federal government for FY2009, including the appropriate budgetary levels for FY2008 and FY2010-FY2013. Title I: Recommended Levels and Amounts - (Sec. 101) Lists recommended budgetary levels and amounts, for FY2008-FY2013, with respect to: (1) federal revenues; (2) new budget authority; (3) budget outlays; (4) deficits (on-budget); (5) debt subject to limit; and (6) debt held by the public. (Sec. 102) Lists the appropriate levels of new budget authority, outlays, and administrative expenses for Social Security, U.S. Postal Service discretionary administrative expenses, and specified major functional [...] show full description
Latest Action: 04/25/2008 - Referred to the Subcommittee on Livestock, Dairy, and Poultry. Bill TextTo authorize appropriations for the seafood inspection regime of the Food and Drug Administration. 1/29/2008--Introduced. Authorizes appropriations to implement the seafood inspection regime of the Food and Drug Administration (FDA).
Also tagged in: Administrative procedure, Business, Congress, Congressional reporting requirements, Consumer education, Consumers, Deceptive advertising, Department of Health and Human Services, Drug adulteration, Drug industry, Drugs, Executive departments, Labeling, Law, Medical care, Medicine
Latest Action: 11/06/2007 - Referred to the House Committee on Energy and Commerce. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes. 11/6/2007--Introduced. Non-Prescription Drug Modernization Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to authorize: (1) the amendment or repeal of an over-the-counter drug monograph without notice and public procedure if there is a finding by the Secretary of Health and Human Services that a category of drugs or a specific drug is associated with a significant risk or that such drugs lack evidence of effectiveness; and (2) the Food and Drug Administration (FDA) to regulate over-the-counter drug advertisements. Directs the Commissioner of Food and Drugs to identify over-the-counter drug monographs that may require amendment or repeal and to report the findings to Congress.
Also tagged in: Administrative procedure, Business, Congress, Congressional reporting requirements, Consumer education, Consumers, Deceptive advertising, Department of Health and Human Services, Drug adulteration, Drug industry, Drugs, Executive departments, Labeling, Law, Medical care, Medicine
Latest Action: 11/06/2007 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Bill TextA bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the amendment or repeal of monographs, to expand the Food and Drug Administration's authority to regulate drug advertising, and for other purposes. 11/6/2007--Introduced. Non-Prescription Drug Modernization Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to authorize: (1) the amendment or repeal of an over-the-counter drug monograph without notice and public procedure if there is a finding by the Secretary of Health and Human Services that a category of drugs or a specific drug is associated with a significant risk or that such drugs lack evidence of effectiveness; and (2) the Food and Drug Administration (FDA) to regulate over-the-counter drug advertisements. Directs the Commissioner of Food and Drugs to identify over-the-counter drug monographs that may require amendment or repeal and to report the findings to Congress.
Also tagged in: Administrative procedure, Administrative remedies, Business, Business records, Communication in medicine, Communications, Consumer protection, Consumers, Criminal investigation, Criminal justice, Criminal justice information, Deceptive advertising, Defective products, Department of Health and Human Services, Directories, Drug adulteration, Drug industry, Drugs, Executive departments, Fines (Penalties), Government information, Government paperwork, Government publicity, Governmental investigations, Health education, Identification devices, Informers, Intellectual property, Labeling, Law, Medical care, Medical personnel, Medicine, Packaging, Product counterfeiting, Subpoena, Technology, Wholesale trade
Latest Action: 11/05/2007 - Referred to the House Committee on Energy and Commerce. Bill TextTo amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. 11/5/2007--Introduced. Tim Fagan's Law or the Counterfeit Drug Enforcement Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to establish a criminal fine and/or imprisonment for a person who: (1) knowingly causes a prescription drug to be adulterated, misbranded, or misrepresented as an approved prescription drug and sells or trades the drug; or (2) purchases or trades for such drug knowing or having reason to know that the drug was knowingly adulterated, misbranded, or misrepresented. Requires a manufacturer of a drug to notify the Secretary of Health and Human Services within 48 hours after first receiving or becoming aware of [...] show full description
Latest Action: 10/09/2007 - Referred to the Subcommittee on Health. Bill TextTo direct the Commissioner of Food and Drugs to revise the Federal regulations applicable to the declaration of the trans fat content of a food on the label and in the labeling of the food when such content is less than 0.5 gram. 10/9/2007--Introduced. Trans Fat Truth in Labeling Act of 2007 - Directs the Commissioner of Food and Drugs to promulgate a final regulation revising federal regulations applicable to the declaration of the trans fat content on a food label to require that if the trans fat content of a serving of a food is less than .5 grams and is declared in the nutrition information on the label or in the labeling of the food, such content shall be expressed through the use of an asterisk or other notation stating that such content is less than .5 grams (instead of zero).
|
